Aims: We aimed to examine how newly diagnosed diabetes and work disability jointly predict death during working age. Methods: We used prospective population-based register data of 25-59-year-old adults who had lived in Sweden since 2002. All those with onset of diabetes recorded in 2006 were included (n=14266). A 2% random sample (n=78598) was drawn from the general population, comprising people with no indication of diabetes during 2003-2010. Net days of sickness absence and disability pension in 2005-2006 were examined; the follow-up time for mortality was 2007-2010.
Introduction
Type 2 diabetes is a growing, notable health and economic challenge [1] , and there is strong evidence that it increases the risk of premature death [2] [3] [4] . Recent evidence further shows that years lived with disability and disability-adjusted life years because of diabetes are increasing [5] . Moreover, while there is a positive trend towards longer life expectancy globally, diabetes as a cause of death is increasing [6] . These issues highlight the need for timely prevention and the identification of key risk groups.
Work disability (sickness absence and disability pension) has also been shown to predict mortality [7, 8] . The risk is increased even after relatively short sickness absence spells (1-30 days) [7] . Moreover, although diagnoses resulting in receipt of a disability pension differ from the most common causes of death, all causes of disability pension have been associated with a higher risk of premature death [8] .
Diabetes has a consistent impact on outcomes related to poorer working capacity [9] . Recent studies The joint contribution of diabetes and work disability to premature death during working age: a population-based study in Sweden have shown that work disability among people with newly diagnosed diabetes is remarkably higher than that among people without diabetes, even before the onset of the disease [10] . This higher risk of work disability among people with diabetes can be attributed to both mental and somatic comorbid conditions [11] . Despite the strong evidence linking diabetes and work disability to mortality, the joint association between diabetes, work disability and risk of death has not been examined. Given that onset of diabetes has been linked with work disability, we need to examine whether people of working age with newly diagnosed diabetes are also at a higher risk of premature death during the years immediately following the diagnosis, and whether the risk is shaped by the length of work disability. Death during working age is a major health and societal issue [12] , but studies linking diabetes with mortality have not specifically considered the risk of premature death during working age.
Our aim was to examine whether work disability more strongly predicts death among working-age people with newly diagnosed diabetes than among people without diabetes using nationwide population-based registers.
Methods
We conducted a prospective population-based cohort study, based on data from the nationwide Insurance Medicine All-Sweden (IMAS) research database [10, 13] . The study population was based on all working-age individuals aged 25 
Measures
Newly diagnosed diabetes was based on inpatient or outpatient specialized care in 2006 (ICD-10 codes E10-E14), or prescribed insulin or any other diabetes medication (Anatomical Therapeutic Chemical (ATC)-code A10) [15] Net days of sickness absence or disability pension in 2005-2006 were divided into four separate groups among both people with and without diabetes: no work disability, less than a month, one to 6 months and over 6 months. The outcome was all-cause mortality over the follow-up of 4 years.
Sociodemographic variables comprised gender, age, educational level, family situation, country of birth and type of living area. Time-dependent chronic health conditions comprised depressive disorders (ATC-code N06 or ICD-10 codes F32-F34), other psychiatric disorders (ATC-code N05 or ICD-10 codes F00-F31 or F35-F99), cardiovascular diseases (ATC-code C01 or ICD-10 codes I20-I25, I46-I49, I60-I69), hypertension (ATC-code C02 or ICD-10 codes I10-I15) and musculoskeletal disorders (ICD-10 codes M00-M99). The timing of these conditions was calculated as either being present already at the beginning of the follow-up in 2007, or incidence in 2008, 2009, or 2010.
Ethics approval
IMAS was approved by the Regional Ethics Review Board, Stockholm, Sweden.
Statistical analyses
We fitted Cox proportional hazard models (hazard ratios, HR, and their 95% confidence intervals, CI). The proportionality of the risk over time is displayed in the survival curve ( Figure 1 ). Model 0 was the unadjusted model. In Model 1, we adjusted for sex and age. Model 2 was adjusted for sex, age, education, family situation, living area and place of birth; and Model 3 was the full model, also including timedependent health conditions. In addition, we estimated the contribution of covariates to the model estimates (% reduction in the effect sizes) using the formula 100*(Beta Model 0 -Beta Model 1 )/(Beta Model 0 ). Finally, we computed synergy indices to examine whether the joint effects of diabetes and work disability on death were additive or synergistic [16, 17] . All analyses were conducted using SAS, version 9.4.
results
Among people with diabetes, 54% had at least one compensated work disability episode in 2005-2006; among their counterparts without diabetes, the corresponding figure was 27% (Table I) . Altogether 1.2% (n=1112) of the participants died during the follow-up. Mortality during the follow-up was fourfold among people with diabetes, compared with people without diabetes. In both groups, mortality increased with increasing work disability, and was at its highest among people with diabetes and work disability lasting over 6 months (6.3%).
Those with diabetes were more likely to be men, older, living with a partner without children, or immigrants, and to have a lower level of education or poorer health than those without diabetes (Table II, all p-values <0.001).
Among people without diabetes, the survival curves for those without work disability and with work disability lasting a month or less were similar, and indicated a low death rate ( Figure 1 ). In addition, most of the individuals without diabetes and with work disability lasting up to 6 months survived over the follow-up, whereas people with diabetes and long-term work disability were at the highest risk of premature death.
Cox regression analyses confirmed that individuals who had diabetes but no indication of work disability were at a higher risk of premature death (crude HR=3.53, 95% CI 2.82-4.42) than their counterparts without diabetes or indication of work disability (Table III) . The association notably attenuated (38%) after adjusting for sex and age, whereas additional adjustments for all sociodemographic factors made a negligible contribution (2%) to the association. The association further attenuated (30% compared with the prior model, and 57% compared with the crude model) after full adjustment, including all the covariates and time-dependent health conditions. The risk of death among people with diabetes increased with increasing work disability length. The crude hazard ratio for the risk of death was 4.64 (95% CI 3.20-6.73) for people with work disability lasting less than Among people without diabetes, the risk of death similarly increased with increasing work disability; among people with work disability from 1 to 6 months, the association (crude HR=1.94, 95% CI 1.42-2.67) was particularly attenuated after full adjustment for all sociodemographic factors and health conditions (47%). Among people with work disability of 6 months or more, the risk was substantially higher (crude HR=6.39, 95% CI 5.41-7.56). This association also attenuated most after the full adjustment (53%).
Finally, the synergistic effect (S) of diabetes and work disability on the risk of premature death was found in the crude model (S=1.87, 95% CI 1.55-2.25). The effect remained after adjusting for gender and age (S=1.61, 95% CI 1.32-1.96), and sociodemographic factors (S=1.58, 95% CI 1.28-1.94), but after full adjustment, the effect diluted (S=1.22, 95% CI 0.91-1.65).
Discussion

Main findings
We sought to examine whether newly diagnosed diabetes and work disability jointly contribute to the risk of premature death during working age among a large population-based cohort from Sweden. The main finding was that diabetes strongly predicts premature death, and that the risk is pronounced among people with long-term work disability. The associations remained strong even after considering sociodemographic factors and time-dependent health conditions, although synergistic interaction effects attenuated.
Previous studies
This is the first study to examine the joint associations between diabetes and work disability, and the risk of death during working age. The results showed that the higher risk of death shown among people with diabetes [2, 3] also applies to premature mortality during working age, and that the risk is higher already during the first years after diabetes diagnosis, even among those without work disability.
A recent study reported that the risk of premature death increases among people with over 30 sick-leave days, but attenuates over time, and disappears after a follow-up of 6 years [18] . In our study, the association similarly followed a gradient, but the risks persisted over the entire follow-up of 4 years.
We focused on all-cause disability and all-cause mortality, and one might assume that the risk is shaped by the causes of work disability and death. Given that diabetes and work disability appear to increase the risk of death due to various causes [2, 3, 7, 8] , and that the risk of death is low overall during working age, we focused on all-cause mortality, emphasizing the importance of the length of work disability and diabetes in the risk of premature death in midlife and working age. Although the associations were consistent and strong, and the gradient was shown throughout the modelling, the risks could still be higher for specific causes, and then non-existent in the case of, for example, some rarer causes. Our recent studies have reported that diabetes is linked to both mental and somatic causes of work disability [10, 11] , which supports the decision to focus on all-cause work disability. As comorbid conditions make a strong contribution to the risk of work disability, particularly in the case of diabetes [10] , and are also likely to affect the risk of death, key health conditions were considered as time-dependent variables in this study. As expected, they attenuated the associations among people both with and without diabetes, but even after considering all key sociodemographic and healthrelated factors, the associations were relatively strong. Synergy index calculations further suggest that diabetes and work disability jointly contribute to the risk of premature death during working age, and that the risk is highest among those with both diabetes and work disability. Health conditions, however, largely account for the synergistic effects. Nonetheless, we also found that people with newly diagnosed diabetes were at a higher mortality risk even without any work disability episodes in the diagnosis year and the year before, when time-dependent health conditions during follow-up had been considered. The reasons for this finding are unknown, but it suggests that people who have diabetes but no work disability might need more adequate care and health monitoring.
Given that about a fifth of all deaths occur during working age in EU countries, our findings highlight not only public health but also the societal relevance of preventive measures, as costs related to each death during working age are substantial [12] . If the risk of developing diabetes could be prevented, this could help reduce the risk of subsequent work disability, comorbidities, and premature death. In countries with a high prevalence of obesity, the group of people with pre-diabetes may also be high [1] , highlighting a need for timely prevention and enhanced means to address the challenge, and detect diabetes already at pre-stage. At the same time, novel means to help tackle the risk of work disability and premature death among individuals with and without diabetes diagnosed during working age are warranted. Those with diabetes inevitably more frequently use healthcare services than their counterparts without chronic conditions. We could assume that this would improve opportunities to detect comorbid conditions earlier and to identify risks of work disability, thereby, reducing the risk of premature death during working age.
Methodological considerations
Limitations. First, we only had data on sickness absence days that involved benefits paid by the Social Insurance Agency (sick-leave periods exceeding 14 days in most cases). People with diabetes might have had more short-term sick-leave periods than those without diabetes; if so, the results regarding differences between the groups would be underestimated. Second, although there was no indication of diabetes in the registers before the study began, the diabetes may have been treated with lifestyle intervention only, or may have remained untreated. It is thus possible that some people in the reference population had undiagnosed or untreated diabetes. Since it is possible to purchase medication for only three months at a time, it is likely that we captured most of those with newly diagnosed diabetes in 2006, and were able to exclude people with prior indication of diabetes. Individuals with only lifestyle-related treatment are likely to be less severe cases who are at a lower risk of work disability and mortality. Data were unavailable from primary health care, which is where most individuals with diabetes are treated. However, our key method to identify diabetes was using prescribed medication purchases. Thus, most of the people treated in primary care are likely to also have been treated with diabetes medication, and were, therefore, included as having diabetes onset in 2006. Moreover, use of oral diabetes medication had strongly increased during a decade prior to 2006 [19] . Specialized health care data were further used to complete the medication data, using additional indications of diabetes. Third, these data do not allow us to distinguish between individuals with type 1 or type 2 diabetes. This is unlikely to bias the examined associations, as there is no particular reason to assume that the joint association between diabetes, work disability and death differed according to diabetes type. In other words, although the prevalence or absolute death rates may vary between the types, if diabetes and work disability are jointly associated with premature death, it is likely that the association is similar for both types. In addition, the majority of newly diagnosed diabetes cases in midlife is likely to be type 2 diabetes, although the age of onset has somewhat decreased [20] . In our cohort of working-aged adults aged 25-59 years at inclusion, we assumed the majority of diabetes incidence to be type 2. Fourth, although register-based data help avoid reporting bias related to survey data, these data only comprise a limited set of covariates. Thus, residual confounding is a potential problem, and we cannot rule out the possibility that we missed some relevant background information. For example, we were unable to control for health behaviours (e.g., smoking, alcohol use, obesity) and poor sleep, which are associated with diabetes, work disability, and mortality [21] [22] [23] [24] [25] . Behavioural risk factors, particularly obesity, also increasingly contribute to the global burden of morbidity and mortality, and altogether over 50% of deaths are attributable to such risk factors [26] . Register-data nonetheless comprise key sociodemographic variables such as education, which could partly act as a proxy for smoking and other health behaviours as well as body weight [27] [28] [29] . Similarly, we had data on marital status and family situation, living area, and immigration, which alongside education explain health behaviours and obesity. In addition, we were able to cover both somatic and mental disorders. These could be seen as potential consequences of adverse health behaviours, while being linked to diabetes, work disability, and a higher risk of death. Although we were unable to account for the contribution of working conditions to diabetes, work disability and death, in our sensitivity analyses occupational class was considered a proxy for physical and psychosocial work (data not shown). The associations were similar to those reported, but since education was a clearer, more stable indicator of socioeconomic position in these data, and largely acquired before the inclusion, we retained education in the analyses.
Strengths. Our major strength was the use of nationwide population-based data which have been found to be suitable for large-scale studies [30] . In-and outpatient registers have been shown to have good validity, and their coverage was very high in the years of this study [30] . The registers are complete, with no attrition or bias due to non-response or self-reports. All working-aged individuals living in Sweden could be included and followed until emigration, death or end of follow-up. Another strength was the opportunity to consider health conditions as time-dependent covariates, something that is seldom done in prospective studies. The inclusion of health conditions enabled us to show more robust associations concerning the joint effects between diabetes and work disability on the risk of premature death. We were further able to cover net days of both medically certified sickness absence and disability pension.
conclusion
Diabetes and work disability jointly associate with subsequent premature death, but diabetes increases the risk of premature death during working age even without work disability. Furthermore, long-term work disability is associated with premature death without diabetes. Diabetes, in combination with long-term work disability, stands out as an indicator of a substantially high risk of premature death, although the causes of death need further examination. Since diabetes and work disability constitute a growing major societal, public health, and individual burden, successful prevention remains a crucial, yet complex challenge, warranting more in-depth scientific knowledge.
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